115 related articles for article (PubMed ID: 1389100)
1. Cancer-associated changes in glycosylation of fibronectin. Immunohistological localization of oncofetal fibronectin defined by monoclonal antibodies.
Mandel U; Hamilton Therkildsen M; Reibel J; Sweeney B; Matsuura H; Hakomori S; Dabelsteen E; Clausen H
APMIS; 1992 Sep; 100(9):817-26. PubMed ID: 1389100
[TBL] [Abstract][Full Text] [Related]
2. Oncofetal fibronectins in oral carcinomas: correlation of two different types.
Mandel U; Gaggero B; Reibel J; Therkildsen MH; Dabelsteen E; Clausen H
APMIS; 1994 Sep; 102(9):695-702. PubMed ID: 7946273
[TBL] [Abstract][Full Text] [Related]
3. An alpha-N-acetylgalactosaminylation at the threonine residue of a defined peptide sequence creates the oncofetal peptide epitope in human fibronectin.
Matsuura H; Greene T; Hakomori S
J Biol Chem; 1989 Jun; 264(18):10472-6. PubMed ID: 2471705
[TBL] [Abstract][Full Text] [Related]
4. Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma.
Kosmehl H; Berndt A; Strassburger S; Borsi L; Rousselle P; Mandel U; Hyckel P; Zardi L; Katenkamp D
Br J Cancer; 1999 Nov; 81(6):1071-9. PubMed ID: 10576667
[TBL] [Abstract][Full Text] [Related]
5. The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6. Unique structural requirement for the antigenic specificity provided by a glycosylhexapeptide.
Matsuura H; Takio K; Titani K; Greene T; Levery SB; Salyan ME; Hakomori S
J Biol Chem; 1988 Mar; 263(7):3314-22. PubMed ID: 2449438
[TBL] [Abstract][Full Text] [Related]
6. Oncofetal fibronectin and oral squamous cell carcinoma.
Lyons AJ; Bateman AC; Spedding A; Primrose JN; Mandel U
Br J Oral Maxillofac Surg; 2001 Dec; 39(6):471-7. PubMed ID: 11735145
[TBL] [Abstract][Full Text] [Related]
7. The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma.
Matsuura H; Hakomori S
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6517-21. PubMed ID: 2995969
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody X18A4 identifies an oncofetal fibronectin epitope distinct from the FDC-6 binding site.
Feinberg RF; Kliman HJ; Bedian V; Monzon-Bordonaba F; Menzin AW; Wang CL
Am J Obstet Gynecol; 1995 May; 172(5):1526-36. PubMed ID: 7538728
[TBL] [Abstract][Full Text] [Related]
9. Deregulated Bag-1 protein expression in human oral squamous cell carcinomas and lymph node metastases.
Hague A; Packham G; Huntley S; Shefford K; Eveson JW
J Pathol; 2002 May; 197(1):60-71. PubMed ID: 12081206
[TBL] [Abstract][Full Text] [Related]
10. Distribution of fibronectin isoforms in human renal disease.
Van Vliet A; Baelde HJ; Vleming LJ; de Heer E; Bruijn JA
J Pathol; 2001 Feb; 193(2):256-62. PubMed ID: 11180174
[TBL] [Abstract][Full Text] [Related]
11. Carbohydrate changes in squamous cell carcinomas.
Dabelsteen E; Clausen H; Mandel U
APMIS Suppl; 1992; 27():130-8. PubMed ID: 1520522
[TBL] [Abstract][Full Text] [Related]
12. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
13. Expression of a developmentally regulated epitope on fibronectins from the synovial fluid of patients with rheumatic disease.
Carsons S; Clausen H; Wolf J
J Rheumatol; 1994 Oct; 21(10):1888-91. PubMed ID: 7530772
[TBL] [Abstract][Full Text] [Related]
14. Fibronectin expression in cancer tissues from patients undergoing radiation therapy.
Nishioka A; Ogawa Y; Inomata T; Maeda T; Seguchi H
Histol Histopathol; 1993 Jul; 8(3):457-62. PubMed ID: 8358157
[TBL] [Abstract][Full Text] [Related]
15. Influences of tumor stroma on the malignant phenotype.
Nielsen JD; Moeslund M; Wandall HH; Dabelsteen S
J Oral Pathol Med; 2008 Aug; 37(7):412-6. PubMed ID: 18331288
[TBL] [Abstract][Full Text] [Related]
16. Production and characterization of monoclonal antibodies showing a different spectrum of reactivity to human breast tissue.
Mandeville R; Giroux L; Lecomte J; Chausseau JP; Dumas F; Ajdukovic I; Vidal D; Boury F
Cancer Detect Prev; 1987; 10(1-2):89-100. PubMed ID: 2436777
[TBL] [Abstract][Full Text] [Related]
17. Development of monoclonal antibodies with specificity to oral squamous cell carcinoma.
Fantozzi RD
Laryngoscope; 1991 Oct; 101(10):1076-80. PubMed ID: 1921634
[TBL] [Abstract][Full Text] [Related]
18. Integrins alpha5beta1, alphavbeta1, and alphavbeta6 collaborate in squamous carcinoma cell spreading and migration on fibronectin.
Koivisto L; Grenman R; Heino J; Larjava H
Exp Cell Res; 2000 Feb; 255(1):10-7. PubMed ID: 10666329
[TBL] [Abstract][Full Text] [Related]
19. Loss of a novel mucin-like epithelial glycoprotein in oral and cervical squamous cell carcinomas.
Nielsen PA; Mandel U; Therkildsen MH; Ravn V; David L; Reis CA; Wandall HH; Dabelsteen E; Clausen H
Cancer Res; 1997 Feb; 57(4):634-40. PubMed ID: 9044839
[TBL] [Abstract][Full Text] [Related]
20. The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acid.
Devine PL; Clark BA; Birrell GW; Layton GT; Ward BG; Alewood PF; McKenzie IF
Cancer Res; 1991 Nov; 51(21):5826-36. PubMed ID: 1718585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
